Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model.
- Published in:
- Autoimmunity, 2015, v. 48, n. 7, p. 460, doi. 10.3109/08916934.2015.1031888
- By:
- Publication type:
- Article